This is of importance, since patients with TAS2R10-expressing pancreatic tumours had a chance of prolonged survival compared to TAS2R10 negative controls [20], whereas no correlation was seen between the expression frequency of TAS2R38 and survival time in another study involving pancreatic cancer patients [26]. This evidence concerns the gene TAS2R38 and pancreatic neoplasm.